Positive crosstalk between EGFR and the TF-PAR2 pathway mediates resistance to cisplatin and poor survival in cervical cancer

por Hugo de Almeida, Vitor, Guimarães, Isabella dos Santos, Almendra, Lucas R., Rondon, Araci M.R., Tilli, Tatiana M., de Melo, Andréia C., Sternberg, Cinthya, Monteiro, Robson Q.
Publicado 2018